Analgesics - Pakistan | Statista Market Forecast

In 2024, revenue in the Analgesics market in Pakistan amounts to US$123.40m.
The market is expected to grow annually by 6.91% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue with US$7.24bn in 2024.
In relation to the total population of Pakistan, per person revenues amount to US$0.50 in 2024.
The demand for analgesics in Pakistan has seen a significant increase due to the growing prevalence of chronic pain conditions among the population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Pakistan has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter pain relief medications, along with local special circumstances and underlying macroeconomic factors.Customer preferences in Pakistan have been a key driver of the growth in the Analgesics market. Consumers in Pakistan have shown a preference for easily accessible and affordable pain relief medications. Over-the-counter analgesics, such as paracetamol and ibuprofen, are popular choices for self-medication due to their effectiveness in relieving common aches and pains. Additionally, the convenience of purchasing these medications without a prescription has contributed to their popularity among consumers.Trends in the market have also played a role in the growth of the Analgesics market in Pakistan. There has been an increasing demand for analgesics with additional benefits, such as those that also provide relief from cold and flu symptoms. This trend can be attributed to the high prevalence of respiratory infections in Pakistan, as well as the desire of consumers to find multi-purpose medications that address multiple symptoms simultaneously. Manufacturers have responded to this trend by introducing combination analgesics that provide relief from both pain and cold symptoms.Local special circumstances have further contributed to the growth of the Analgesics market in Pakistan. The country has a large population, which creates a significant market for pain relief medications. Additionally, the lack of access to healthcare facilities in remote areas of Pakistan has led to an increased reliance on over-the-counter analgesics for self-medication. This has driven the demand for these medications and contributed to the growth of the market.Underlying macroeconomic factors have also played a role in the development of the Analgesics market in Pakistan. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among consumers. As a result, consumers have more purchasing power to spend on healthcare products, including pain relief medications. This has fueled the demand for analgesics in the market.In conclusion, the Analgesics market in Pakistan has been growing steadily due to customer preferences for over-the-counter pain relief medications, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience, affordability, and effectiveness of over-the-counter analgesics have made them a popular choice among consumers in Pakistan. The demand for analgesics with additional benefits, such as relief from cold and flu symptoms, has also contributed to the growth of the market. The large population and lack of access to healthcare facilities in remote areas have further driven the demand for over-the-counter analgesics. Finally, the steady economic growth in Pakistan has increased consumers' purchasing power and fueled the demand for pain relief medications.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.